Summit Therapeutics Inc.SMMTNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+132.9%
5Y CAGR+72.5%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+132.9%/yr
vs +7.8%/yr prior
5Y CAGR
+72.5%/yr
Recent acceleration
Acceleration
+125.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
15.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $812.13M | +284.3% |
| 2024 | $211.30M | +141.0% |
| 2023 | $87.69M | +36.4% |
| 2022 | $64.28M | -26.9% |
| 2021 | $88.00M | +65.4% |
| 2020 | $53.19M | +35.8% |
| 2019 | $39.18M | -17.8% |
| 2018 | $47.69M | -11.9% |
| 2017 | $54.13M | +59.5% |
| 2016 | $33.95M | - |